The International Society for Stem Cell Research and a coalition of 98 scientific, medical, and patient communities dedicated to advancing medical knowledge and improving human health urged President-elect Biden to swiftly rescind the human fetal tissue research restrictions and policy changes that the Department of Health and Human Services made in 2019.

Among other key points, the letter stated that these changes have halted all intramural human fetal tissue research and obstructed new extramural research involving human fetal tissue.

Scientists and ethicists have repeatedly reviewed the use of human tissue in research and have consistently concluded that it is an essential resource for biomedical research.

Human fetal tissue has led to many scientific and medical advances that have saved millions of lives. It remains critical for the development of new treatments for a wide range of serious diseases, including Covid-19.

Read the letter.

The above comes from a Jan. 7 release by the International Society for Stem Cell Research.